The effects of prescribing varenicline on two-year health outcomes: an observational cohort study using electronic medical records.

Neil Martin Davies Gemma M J Taylor Amy E Taylor Timothy JonesRichard M MartinMarcus R Munafo Frank WindmeijerKyla H Thomas

Published in: Addiction (Abingdon, England) (2018)

Smokers prescribed varenicline in primary care in the United Kingdom do not appear to be less likely to die, be hospitalized or experience a myocardial infarction or chronic obstructive pulmonary disease during the following 2 years compared with smokers prescribed nicotine replacement therapy, but they gain more weight and attend primary care less frequently.

Keyphrases

smoking cessation
primary care
replacement therapy
chronic obstructive pulmonary disease
general practice
heart failure
cross sectional
left ventricular
weight loss
physical activity
lung function
weight gain
emergency department
air pollution
atrial fibrillation